Document Detail


Device-based therapies for resistant hypertension.
MedLine Citation:
PMID:  23173589     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hypertension is universally considered the most detrimental among cardiovascular risk factors. Despite the overwhelming evidence of benefits deriving from lowering blood pressure, its control among the hypertensive population is still unsatisfactory. Resistant hypertension has a non negligible prevalence among hypertensive patients, and it is associated with a worse cardiovascular prognosis. There is need of new therapeutic approaches for reducing cardiovascular risk in this population. Sympathetic nervous system is known to play a major role in development and maintenance of essential hypertension, thus in the past decades several efforts have been made to counteract its overactivation. Novel non-pharmacological, promising approaches targeting sympathetic nervous system are now available, such as renal denervation and baroceptor-activating therapy. This review is aimed at describing essential clinical aspects of resistant hypertension, physiopatological basis of autonomic modulation as a target for hypertension treatment, and the available clinical evidence about efficacy and safety of device-based therapies for resistant hypertension. Present limitations and future perspectives were also considered.
Authors:
Rosa Maria Bruno; Alessia Di Giulio; Giampaolo Bernini; Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Related Documents :
7902189 - Microinjections of glutamate within trigeminal subnucleus interpolaris alters adrenal a...
24715229 - Association between bioimpedance analysis parameters and left ventricular hypertrophy i...
14500179 - Men are more susceptible than women to direct pressure on unmyelinated ulnar nerve fibers.
1970509 - L-glutamate mapping of cardioreactive areas in the rat posterior hypothalamus.
3266589 - The region of medial forebrain bundle is involved in tonic maintenance of arterial pres...
2547299 - Interactions between circulating peptides and the central nervous system in hemodynamic...
13932039 - Electrophysiology of an insect heart.
21046489 - Dual-acting angiotensin receptor-neprilysin inhibition.
20719579 - Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular h...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-19
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. rosam.bruno@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional and structural alterations of large arteries: methodological issues.
Next Document:  Sleep Loss and Hypertension: a systematic review.